Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 23 | 18 | 10 | 0 |
| Cost of Goods | 33,783 | 28,188 | 19,925 | 10,473 | 14,645 |
| Gross Profit | -33,783 | -28,165 | -19,907 | -10,463 | -14,645 |
| Operating Expenses | 4,226 | 5,130 | -796 | 3,687 | 3,590 |
| Operating Income | -38,009 | -33,295 | -19,111 | -14,150 | -18,235 |
| Interest Expense | 2,062 | 1,586 | 469 | 31 | 42 |
| Other Income | -56 | -9 | 12 | 108 | 299 |
| Pre-tax Income | -40,127 | -34,890 | -19,568 | -14,073 | -17,978 |
| Income Tax | -2,575 | -4,257 | -3,769 | -2,692 | -3,519 |
| Net Income Continuous | -37,552 | -30,633 | -15,799 | -11,381 | -14,459 |
| Net Income Extraordinary | N/A | N/A | -23 | 159 | 152 |
| Net Income | $-37,551 | $-30,634 | $-15,823 | $-11,223 | $-14,308 |
| EPS Basic Total Ops | -1.55 | -2.51 | -1.55 | -1.13 | -1.47 |
| EPS Basic Continuous Ops | -1.55 | -2.51 | -1.55 | -1.15 | -1.49 |
| EPS Diluted Total Ops | -1.55 | -2.51 | -1.55 | -1.13 | -1.47 |
| EPS Diluted Continuous Ops | -1.55 | -2.51 | -1.55 | -1.15 | -1.49 |
| EBITDA(a) | $-37,999 | $-33,224 | $-19,028 | $-13,949 | $-17,861 |